Skip to content

An observational study for thrombus regression by anti-coagulation therapy in venous thromboembolism

An observational study for thrombus regression by anti-coagulation therapy in venous thromboembolism - VTE thrombus regression by anticoagulants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000019910
Enrollment
90
Registered
2015-12-01
Start date
2015-11-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous thromboembolism

Interventions

None listed

Sponsors

Gunma University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed as pulmonary embolism and/or deep vein thrombosis and newly started anticoagulant/

Exclusion criteria

Exclusion criteria: Acute myocardial infarction, acute heart failure, thrombolysis, active bleeding, contraindication for anticoagulants

Design outcomes

Primary

MeasureTime frame
Thrombus regression estimated by CT scan or venous echo in 6 months.

Secondary

MeasureTime frame
Thrombus regression estimated by CT scan or venous echo in 1 month.

Countries

Japan

Contacts

Public ContactNorimichi Koitabashi

Gunma University Hospital Department of Cardiovascular Medicine

norikoitabashi@gmail.com027-220-8145

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026